GOVX:NASDAQ
Geovax Labs Inc
$0.48
arrow_downward
-4.68%(-0.024) 1D
$0.50
arrow_upward
+3.50% (+0.017)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.53
High
$0.53
Low
$0.48
Mkt. cap
3.54M
Avg. vol.
899.51K
Volume
550.73K
52-wk high
$19.00
52-wk low
$0.48
EPS
-$13.92
Beta
3.66
Shares outstanding
7.37M
No. of employees
19
Open
$0.53
High
$0.53
Low
$0.48
Mkt. cap
3.54M
Avg. vol.
899.51K
Volume
550.73K
52-wk high
$19.00
52-wk low
$0.48
EPS
-$13.92
Beta
3.66
Shares outstanding
7.37M
No. of employees
19
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com